ADAR1 Capital Management’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$177K Buy
35,000
+20,000
+133% +$101K 0.03% 149
2025
Q1
$79.4K Hold
15,000
0.01% 167
2024
Q4
$101K Hold
15,000
0.02% 171
2024
Q3
$98.9K Buy
+15,000
New +$98.9K 0.02% 175